Search results for "splenectomy"

showing 6 items of 56 documents

Concomitant inflammatory pseudotumor of the liver and spleen

2001

We report the case of a 53-year-old man with inflammatory pseudotumor (IPT) of the liver and spleen. This concomitant association has rarely been reported. The patient presented with a hypoechoic mass in the liver and a clinical picture of recurrent sepsis; hematochemical exams and imaging data were nonspecific. Antibiotic therapy improved the clinical course, but did not resolve it definitively. After 50 days of therapy, as the hepatic mass decreased a similar lesion appeared in the spleen. The final diagnosis was made on splenectomy and an intra-operative biopsy of the residual liver lesion. The diagnostic problems encountered in this very rare association of IPT of the liver and spleen w…

medicine.medical_specialtyPathologyHepatologymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentSplenectomySpleenHepatologymedicine.diseaseSepsisLesionmedicine.anatomical_structureInternal medicineBiopsymedicineInflammatory pseudotumorSplenic diseasemedicine.symptombusinessLiver
researchProduct

OC-87 Gaucher disease in romania – baseline characteristics, specific diagnosis. treatment and outcome

2017

Gaucher disease is a autosomal recessive inherited monogenic disease caused by beta-glucocerebrosidase deficiency. Clinically, there are three types: type 1 (non-neuronopathic), type 2 (acute neuronopathic) and type 3 (chronic neuronopathic), in 92%, 1% and respectively 7% of patients. Specific diagnosis has been possible in Romania since 1997 and enzyme replacement therapy since 2002. The aim of the study is to present the epidemiologic, clinical and molecular data of the Romanian patients with Gaucher disease ant their evolution. Patients and methods Seventy-nine patients (76 patients with Gaucher disease type 1 and 3 patients with Gaucher disease type 3; F/M=1.37/1) were evaluated clinic…

medicine.medical_specialtyPediatricsBone densityImigluceraseBone diseasebusiness.industryIncidence (epidemiology)medicine.medical_treatmentSplenectomyPrevalenceEnzyme replacement therapyDiseasemedicine.diseaseGastroenterologyInternal medicineMedicinebusinessmedicine.drugOral Communications
researchProduct

A case of splenic rupture: A rare event after laparoscopic cholecystectomy

2014

Background Laparoscopic cholecystectomy (LC) is generally safe and well-accepted. In rare cases, it is associated with complications (intra- e postoperative bleeding, visceral injury and surgical site infection). Splenic lesion has been reported only after direct trauma. We report an unusual case of splenic rupture presenting after “uncomplicated” LC. Case presentation A 77-year-old woman presented with distended abdomen, tenderness in the left upper quadrant and severe anemia 12 hours after LC. Clinical examination revealed hypovolemic shock. Abdominal computed tomography confirmed the diagnosis of splenic rupture, and the patient required an urgent splenectomy through midline incision. Th…

medicine.medical_specialtySplenic Capsulemedicine.medical_treatmentSplenectomySpleenPhysical examinationCase ReportRuptured spleenLaparoscopic cholecystectomyPneumoperitoneummedicineHumansSplenic injury Ruptured spleen Laparoscopic cholecystectomyAgedSplenic DiseasesHematomamedicine.diagnostic_testbusiness.industryShockGeneral MedicineSplenic Rupturemedicine.diseaseSplenic injurySurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureCholecystectomy LaparoscopicHemoperitoneumRuptured spleenAbdomenSurgeryFemaleComplicationbusiness
researchProduct

Sclerosing Angiomatoid Nodular Transformation: Laparoscopic Splenectomy as Therapeutic and Diagnostic Approach at the Same Time

2018

Introduction. Sclerosing angiomatoid nodular transformation (SANT) of the spleen is a rare benign vascular lesion with unknown etiopathogenesis and with definite features of imaging, histopathology, and immunohistochemistry. It was first described by Martel et al. in 2004, and to date, only 151 cases have been reported.Case Description. We report a case of SANT of the spleen detected in a 66-year-old Caucasian, without comorbidities, presented to our department with epigastric pain. We, also, presented a review of the literature.Conclusions. SANT is a benign incidentally vascular condition in the majority of cases. The wide age and gender distribution in our review is in accordance with tha…

medicine.medical_specialtybusiness.industrySclerosing angiomatoid nodular transformation spleen.medicine.medical_treatmentSplenectomylcsh:SurgeryCase ReportVascular lesionlcsh:RD1-811Case descriptionSettore MED/08 - Anatomia PatologicaLaparoscopic splenectomyEpigastric painSurgeryAge and gender03 medical and health sciencesSettore MED/18 - Chirurgia Generale0302 clinical medicine030220 oncology & carcinogenesismedicine030211 gastroenterology & hepatologyPharmacology (medical)HistopathologyRadiologybusinessCase Reports in Surgery
researchProduct

Hematopoietic Peripheral Circulating Blood Stem Cells As an Independent Marker of Good Transfusion Management in Patients with Beta-Thalassemia

2015

Abstract Aim Aim of the current study was to prospectively evaluate the potential role of peripheral circulating CD34+ stem cells as new independent marker of appropriate hemopoietic balance in patients with thalassemia major and intermedia. Materials and methods Peripheral blood samples from patients with thalassemia major (TM) and intermedia (TI) were drawn. Peripheral circulating CD34+ stem cells, CF-GEMM, CFU-GM and BFU-GM were assayed with monoclonal antibodies for CD34 and clonogenic tests, according to standard procedures and ISHAGE method (BD stem cell enumeration kit, Becton Dickinson; H4434, Stem Cell Technology). Demographic and clinical data were recorded from each enrolled subj…

medicine.medical_specialtybusiness.industryThalassemiamedicine.medical_treatmentImmunologySplenectomyCD34Becton dickinsonBeta thalassemiaCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyHaematopoiesisInternal medicineCirculating Hematopoietic stem cells beta-thalassemiatrasfusionmedicineStem cellClonogenic assaybusinessBlood
researchProduct

Palliative splenic irradiation in primary and post PV/ET myelofibrosis: outcomes and toxicity of three radiation schedules

2009

Splenectomy and splenic irradiation (SI) are the sole treatment modalities to control drug resistant splenomegaly in patients with myelofibrosis (MF). SI has been used in poor surgical candidates but optimal total dose and fractionation are unclear. We retrospectively reviewed 14 MF patients with symptomatic splenomegaly. Patients received a median of 10 fractions in two weeks. Fraction size ranged from 0.2–1.4 Gy, and total dose varied from 2–10.8 Gy per RT course. Overall results indicate that 81.8% of radiation courses achieved a significant spleen reduction. Splenic pain relief and gastrointestinal symptoms reduction were obtained in 94% and 91% of courses, respectively. Severe cytopeni…

medicine.medical_specialtypalliationmedicine.medical_treatmentSplenectomyMyelofibrosisSpleenSubgroup analysisGastroenterologyArticleInternal medicineMedicinemyelofibrosis; splenomegaly; palliation; radiotherapy; low-dose irradiationMyelofibrosisAdverse effectradiotherapylow dose irradiationsplenomegalylcsh:RC633-647.5business.industrylow-dose irradiation.lcsh:Diseases of the blood and blood-forming organsHematologymedicine.diseaseSurgeryRadiation therapymedicine.anatomical_structureTolerabilityToxicitybusinessHematology Reports
researchProduct